Abcely

Abcely is a French biotechnology company founded in 2019, headquartered in Paris, focused on pioneering orally active secretory IgA (sIgA)-based immunotherapies. The company is developing a first-in-class platform to create biologic drugs specifically designed to treat mucosal cancers and chronic mucosal diseases. Its mission is to revolutionize treatment approaches by enabling targeted, oral delivery to mucosal tissues, addressing significant limitations of traditional systemic antibody therapies.